Background
Chlamydia trachomatis is a sexually transmitted infection that is easily diagnosed and treated, but most infections go undetected since up to 80% are asymptomatic [
1,
2]. If left untreated chlamydia can cause pelvic inflammatory disease which in turn can lead to tubal factor infertility and ectopic pregnancy [
3,
4]. Chlamydia is the most commonly notified infection in Australia with more than 80,000 cases reported in 2013, a three-fold increase in the last decade [
5]. The burden of chlamydia is highest among young Aboriginal and/or Torres Strait Islander people (hereafter ‘Aboriginal’) [
6‐
8]. Notification rates among Aboriginal people are 24 times higher than among non-Indigenous people [
9]; however, notification rates are subject to testing biases [
10,
11].
The focus of the Council of Australian Government’s commitment to
Closing the Gap in health difference and life expectancy between non-Indigenous and Aboriginal peoples is principally directed towards mortality reduction from chronic disease and improvements to child and maternal health [
12], with little focus on sexually transmissible infections (STIs) despite these causing substantial ill health among Aboriginal people. However, included within the
Closing the Gap initiative are measures to improve surveillance systems that lead to increased understanding of disease among Aboriginal people and communities.
In this paper we report patient demographics, completeness of recording of patients’ Aboriginal status, chlamydia testing and positivity rates during 2009, within three ACCESS clinical networks providing primary care: sexual health services (SHSs), general practice (GP) clinics and Aboriginal Community Controlled Health Services (ACCHSs).
Discussion
This report adds significantly to our understanding of the health care utilisation by young Aboriginal people and complements STI notification data by informing chlamydia positivity across a range of primary care services- two generalist (GP and ACCHSs) and one specialised (SHSs). The study is the first comprehensive analyses, and certainly the biggest that compares Aboriginal/non-Aboriginal populations using the same recruitment methods for both populations. Previous comparisons have been based virtually entirely on notification data, which is subject to variabililty due to dependence on testing uptake.
Data from three different types of primary care services are represented, covering a period of 12 months with over 60,100 patients. Elsewhere, we reported the representativeness of participating sites according to Australian population distributions [
13]. Accordingly, results particularly related to Chlamydia testing and positivity are likely to be generalisable to the Australian population aged 16–29 years.
At the participating services, 4.1% of clients at SHSs were identified as Aboriginal, compared to 1.3% at GP clinics and 85% at ACCHSs. Aboriginal attendances in GPs and ACCHSs from this dataset were consistent with those reported in national audits across all ages, and affirm that young Aboriginal people only make up a small proportion of those attending mainstream encounters the patient identified as sexual health services for STI care and management. Of all patients attending GP clinics in 2011–2012 1.5% were identified as Aboriginal [
15] while 78% of patients who attended ACCHS in 2010–2011 were identified as Aboriginal [
16]. Given that young Aboriginal people make up 4% of Australia’s total 15–29 year old population [
17], further efforts are required to make GP services more accessible to them. It should be noted however that young men accessed SHSs more than the GP clinics and ACCHSs; this is likely for two reasons (i) either they are accessing clinics on their own or (ii) they attend as named contacts. Whatever the case, all services should be encouraged to promote their services to young men.
The Aboriginal status of patients was better recorded at ACCHSs and SHSs compared with GP clinics where only one third of patients status was recorded. Improving data quality on Aboriginal status within GP clinics is a priority of Australian Governments [
18] with the Close the Gap Indigenous health incentive payment aiming to improve recording of Aboriginal status [
19].
This study confirms that the majority of ACCHSs patients are Aboriginal people and that people aged 16–29 years attend these services for health care, including for STI screening. This concurs with two previous studies, the first, a cross sectional survey of young people aged 16–29 years where 54% reported that they had an STI test in the previous year and did so at an ACCHS [
20], and a second study of resilience related to STI and blood borne viruses whereby young people reported positive aspects of attending an ACCHS for STI and BBV screening and management. In the latter study, young Aboriginal people described the comfort and understanding they experienced at the ACCHS; and positive personal relationships especially with Indigenous care providers [
21]. Our results support the central role that ACCHSs play in STI service provision for Aboriginal people.
Further efforts are required to improve STI testing rates in primary care. Testing rates among Aboriginal patients attending ACCHSs and GP clinics were quite different with testing rates within ACCHS almost five times greater than that offered by GPs for both Aboriginal and non-Indigenous patients. As expected, testing rates were high among both Aboriginal and non-Indigenous patients attending SHSs. There are two main reasons to test for Chlamydia- to screen those who are asymptomatic or to diagnose symptomatic infection. Thus, chlamydia testing rates of services may reflect their adherence to screening protocols, as well as the burden of disease affecting their populations. With regards to screening, clinical practice guidelines recommend that all sexually active people up to the age of 29 years be offered a chlamydia test at least annually [
22,
23]. The lower rates of testing within GPs and ACCHSs compared with SHSs could be due to a number of factors: patients declining testing; patients not being offered testing (staff lacking awareness of screening guidelines, due lack of time and awareness about chlamydia testing amongst clinic staff, or sensitivities regarding sexual health issues); or other clinical priorities [
24‐
26]. In order to achieve higher chlamydia testing rates in GP and ACCHS settings, supportive quality improvement strategies are warranted [
27,
28] as well as initiatives such as offering a test to all patients prior to the consultation [
29] Quality improvement audits are a key feature of the
Closing the Gap funding initiatives particularly involving ACCHSs [
30] but do not currently explore STI testing patterns.
Mathematical modelling has suggested that increasing rates of chlamydia testing to 40% in males and females aged less than 25 years or to 20% in young people aged less than 30 years could halve the prevalence of chlamydia within ten years; with most of this decline occurring within the first four years [
31]. If the intent is to achieve high chlamydia testing rates in the population, health promotion and clinical education and systems within ACCHS and GPs should address the different health care utilisation patterns of Aboriginal females and males; since in most ACCESS sites a higher proportion of females either attended or were tested than males.
A key strength of this study is that the results reflect actual clinical practice in the participating health services. All data were collected retrospectively and thus did not influence the decision to offer a chlamydia test or not. In addition, within each network, study data were collected from services that are geographically dispersed across the country; thus reducing biases introduced when data are reported from one service or region.
A limitation of the study was the poor identification of Aboriginal patients at mainstream GP clinics with more than two thirds of patients having an unknown Aboriginal status. The poor completeness of Aboriginal status in GP clinics means we cannot be confident about the true testing and positivity rates in Aboriginal patients. In addition, the study did not record patients who declined to have a test when offered one. Clinical audits would be needed to measure the extent of decline in any of these primary care facilities. Further, we were not able to identify symptomatic patients from asymptomatic patients making interpretation of positivity results difficult to correlate with community prevalence rates. Only first patient visits involving Chlamydia testing were counted, thus excluding subsequent testing and positivity data. Finally, in view of the small sample size of GP clinics and ACCHSs in the ACCESS network, these findings may not be representative of all such health services because of the small sample size of these clinics in Australia.
Acknowledgements
We thank all sentinel sites which provided data for ACCESS.
ACCESS is a collaboration between the Kirby Institute, the Burnet Institute, the National Serology Reference Library, the National Perinatal Statistics Unit, and the National Aboriginal Community Controlled Health organization.
ACCESS was overseen by a coordinating committee from 2007–2010 which included: Basil Donovan, Rebecca Guy, John Kaldor, James Ward, Hammad Ali - the Kirby Institute, Sydney, NSW; Margaret Hellard, Jane Goller, Fabian Kong, Caroline van Gemert - Burnet Institute, Melbourne, VIC; Elizabeth Sullivan - Perinatal and Reproductive Epidemiology Research Unit, Sydney, NSW; Wayne Dimech - National Serology Reference Laboratory, Fitzroy, VIC.
The ACCESS project in 2009 was funded by the Australian Government, Department of Health and Ageing. However the views expressed in this paper are not necessarily the views of the Department of Health and Ageing now known as Department of Health.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JW conceptualized the study. JW, JG, HA and AB conducted the analysis. JW drafted the manuscript with assistance from JG, HA, RJG, SC and BD. JW, JMK, MH, RJG and BD are investigators on ACCESS. All authors contributed to the manuscript and read and approved the final version.